These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 5715963)

  • 21. [Antibacterial in-vitro activity of pipemidic acid and nalidixic acid (author's transl)].
    Peters G; Freiesleben H; Marre R; Metz H; Tannenberg H; Pulverer G
    Dtsch Med Wochenschr; 1979 Jun; 104(26):946-8. PubMed ID: 110574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of new quinazolone derivatives of nalidixic acid as potential antibacterial and antifungal agents.
    Grover G; Kini SG
    Eur J Med Chem; 2006 Feb; 41(2):256-62. PubMed ID: 16260068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Isolation and identification of 100 Salmonella strains: in vitro sensitivity and resistance to 25 chemoantibiotic agents].
    Robba L; Radice E; Marchiaro G
    Clin Ter; 1977 Oct; 83(1):37-46. PubMed ID: 589947
    [No Abstract]   [Full Text] [Related]  

  • 24. Belgian multicenter in vitro study of norfloxacin.
    Verbist L
    Acta Clin Belg; 1985; 40(3):167-73. PubMed ID: 3161262
    [No Abstract]   [Full Text] [Related]  

  • 25. [Selection of chemotherapeutic agents for the resistance determination of fast growing bacteria (minimal requirements)].
    Dtsch Med Wochenschr; 1972 Feb; 97(8):303-4. PubMed ID: 4333596
    [No Abstract]   [Full Text] [Related]  

  • 26. [Relationship between bacterial sensitivity to antimicrobial agents and their consumption (author's transl)].
    Jarlier V; Sinègre M; Bismuth R; Nguyen J
    Nouv Presse Med; 1981 Nov; 10(43):3545-8. PubMed ID: 7322881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in nalidixic acid resistance in nontyphoidal Salmonella isolated from 1999 to 2002: decreased susceptibility to 6 fluoroquinolones.
    Rodriguez-Avial I; Rodriguez-Avial C; López O; Picazo JJ
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):261-4. PubMed ID: 15893900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
    Vuye A
    Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents.
    Neu HC; Chin NX; Labthavikul P; Saha G
    Chemioterapia; 1984 Aug; 3(4):235-41. PubMed ID: 6241847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the in vitro sensitivity of Furadantin and Nalidixic acid (Wintomylon) on urinary pathogens.
    Bissessar R; Chen WN
    West Indian Med J; 1970 Mar; 19(1):48-53. PubMed ID: 5502005
    [No Abstract]   [Full Text] [Related]  

  • 31. [Altered chemioantibiotic sensitivity of recently isolated salmonellae].
    Abbate GF; Alagia I; D'Aprea L; Esposito R; Leonessa V
    G Ital Chemioter; 1977; 24(1-2):17-21. PubMed ID: 615758
    [No Abstract]   [Full Text] [Related]  

  • 32. Norfloxacin--a new antibacterial agent with anti-pseudomonal activity.
    Peddie BA
    N Z Med J; 1982 Oct; 95(717):712. PubMed ID: 6216426
    [No Abstract]   [Full Text] [Related]  

  • 33. Cross resistance of quinolone derivatives in gram-negative bacteria.
    Barba D; Pennucci C; Esposito S; Galante D
    Chemioterapia; 1985 Apr; 4(2):192-6. PubMed ID: 3159488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Laboratory control of chemotherapy].
    Zahradnický J
    Cas Lek Cesk; 1972 Nov; 111(45):1050-2. PubMed ID: 4484657
    [No Abstract]   [Full Text] [Related]  

  • 35. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Chemioterapia; 1987 Feb; 6(1):17-22. PubMed ID: 3470153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nalidixic acid resistance in Salmonella strains with decreased susceptibility to ciprofloxacin isolated from humans in Turkey.
    Ercis S; Erdem B; Hasçelik G; Gür D
    Jpn J Infect Dis; 2006 Apr; 59(2):117-9. PubMed ID: 16632912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative in vitro studies of nalidixic acid, oxolinic acid, and a new analog with thieno (2,3-b) pyridine structure.
    Gilis PM; Haemers A; Pattyn SR
    Antimicrob Agents Chemother; 1978 Mar; 13(3):533-5. PubMed ID: 263890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inhibition of Proteus sp. by Nalidixic acid].
    Christoffersen AB
    Nord Vet Med; 1976 Nov; 28(11):564-9. PubMed ID: 825831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Transferable resistance is cultures of Salmonella typhimurium isolated in Recife].
    Magalhães M; Véras A
    Rev Inst Med Trop Sao Paulo; 1975; 17(2):75-8. PubMed ID: 1098123
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antibacterial effect of newer quinolones and nalidixic acid against mastitis pathogens of cattle].
    Gedek W
    Dtsch Tierarztl Wochenschr; 1987; 94(10):545-8. PubMed ID: 3322768
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.